NCT02171247View on ClinicalTrials.gov

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

PHASE3CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Coronary Computed Tomographic Angiography

Interventions

DRUG

Isovue 370

Isovue 370 is a contrast agent with increased iodine concentration.

DRUG

Visipaque 320

Visipaque 320 is standard protocol.

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER